Click to zoom

Mepilex Ag combines the unique features of Safetac technology with the bacteria reducing power of silver. Mepilex Ag goes to work quickly, inactivating wound pathogens within 30 minutes and for up to 7 days. At dressing removal, Mepilex Ag does not stick to the wound or strip surrounding skin, minimising patient pain and wound trauma.

Minimising trauma and pain
Mepilex Ag hurts less by:
• not adhering to the moist wound bed
• eliminating skin stripping
• sealing the wound margins to
• prevent maceration

Reducing bacterial burden
Mepilex Ag in action:
• inactivates wound pathogens within 30 minutes
• inactivates wound pathogens up to 7 days
• inactivates a broad range of pathogens, including MRSA

Exudate management and other benefits
Mepilex Ag features many more important benefits:

• excellent conformability for better
• patient comfort and dressing fit
• good exudate management
• properties
• can be cut to suit various wound
• sizes and difficult-to-dress areas
  

Mepilex Ag is an antimicrobial soft silicone foam dressing that is designed for the management of low to moderately exuding wounds such as leg and foot ulcers, pressure ulcers and partial thickness burns.

Mepilex Ag is not for every patient but for those with wounds that don’t heal normally. If the bacterial influence is too high it needs to be reduced in order not to interfere with the wound healing. Common signs of high bacterial influence are shown below:

• Redness
• Increasing exudate
• Odour
• Signs of pseudonomas
• Spreading redness
• Odema
• Wound healing does not progress normally
• Spreading redness
• Patient in pain
• Increased skin temperature
• Odema

Clinical and Scientific Evidence

Barrows C. Enhancing patient outcomes – reducing the bottom dollar: the use of antimicrobial soft silicone foam dressings in home health. Poster presentation. 21st Annual Symposium on Advanced Wound Care and the Wound Healing Society Meeting, San Diego, California, United States of America 2008
View

 
Blakely M, Weir D. The innovative use of Safetac soft silicone in conjunction with negative pressure wound therapy: three case studies. Poster presentation. 20th Annual Symposium on Advanced Wound Care and the Wound Healing Society Meeting, Tampa, Florida, United States of America 2007
View
 

Davoudi M et al. Multiple actions of Mepilex Ag, a new antimicrobial wound dressing. Poster presentation. European Wound Management Association Conference, Glasgow, United Kingdom 2007

Durante CM. Chronic wounds and local malpractice: an antimicrobial silver soft silicone foam can help solving the problem. Poster presentation. Third Congress of the World Union of Wound Healing Societies, Toronto, Canada 2008
View
 

Taherinejad F et al. Instant and sustained antimicrobial effect of a novel silver containing soft silicone foam dressing against common wound pathogens. Poster presentation. 20th Annual Symposium on Advanced Wound Care and the Wound Healing Society Meeting, Tampa, Florida, United States of America 2007
 

Meites H, Jett M, Gauthier S, Wilson K, Silverstein P. The examination of antimicrobial soft silicone foam with regards to partial thickness burns. Poster presentation. Third Congress of the World Union of Wound Healing Societies, Toronto, Canada 2008
View
 

Nisbet TAS. Promoting complex wound healing through the utilization of an antimicrobial soft silicone foam dressing: solving the wound puzzle one piece at a time. Poster presentation. 21st Annual Symposium on Advanced Wound Care and the Wound Healing Society Meeting, San Diego, California, United States of America 2008
View
 

Schumann H et al. Open, non-comparative, multicentre investigation exploring the tolerance of an absorbent foam dressing containing silver used in chronic wounds. Poster presentation. European Wound Management Association Conference, Glasgow, United Kingdom 2007
View
 

Timmins J. Management of a large haematoma with a new silver impregnated foam dressing. Poster presentation. European Wound Management Association Conference, Lisbon, Portugal 2008
View